⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NXTS News
Nexentis Technologies Inc. Common Stock
Nexentis Announces Reverse Stock Split
globenewswire.com
NXTS
Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz
globenewswire.com
NXTS
Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage
globenewswire.com
NXTS
Form 8-K
sec.gov
NXTS
Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis
globenewswire.com
NXTS
Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
globenewswire.com
NXTS
Form 8-K
sec.gov
NXTS
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
globenewswire.com
NXTS
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
globenewswire.com
NXTS
Form 8-K
sec.gov
NXTS